Takeda (Austria)

Recent papers from Takeda (Austria)

1. Virus Safety of Blood and Plasma Products: From Established Threats to Emerging UncertaintiesPathogens · 2026
2. A nanopore-based next-generation sequencing workflow for comprehensive adventitious virus testingScientific Reports · 2026
3. Serosurvey for Antibodies to Bourbon Virus and Related Thogotoviruses in Immunoglobulin Lots Obtained From Human Plasma Collected in the United States and EuropeThe Journal of Infectious Diseases · 2026
4. Optimizing Development of Plain Language Summaries of Clinical Trial ResultsHLRP Health Literacy Research and Practice · 2026
5. Design Space Assessment of Virus Inactivation in Plasma‐Derived Matrices Establishes a Single Detergent Alternative to TX‐100‐Containing MixesBiotechnology and Bioengineering · 2026
6. P69 | Real-World Usage of Hyaluronidase-Facilitated Subcutaneous Immunoglobulin 10% in Patients With Multiple Myeloma Diagnosed With Secondary Immunodeficiency: An Interim AnalysisSHILAP Revista de lepidopterología · 2026
7. Gaussian Processes for Predictive QSAR Modeling of Chromatographic Processes.2026
8. Intravenous Delivery of a Gene Therapy Vector that Expresses an Antitransferrin Receptor 1 Nanobody-I2S Fusion Protein Rescued Central Nervous System Lysosomal Burden in Mucopolysaccharidosis II MiceHuman Gene Therapy · 2025
9. Challenges for Visual Inspection and Particle Control in Cell Therapy ProductsPDA Journal of Pharmaceutical Science and Technology · 2025
10. Protein Polarimetry, Perfected: Specific Rotation Measurement for the Refracto-Polarimetric Detection of Cryptic Protein DenaturationBiophysica · 2025
11. Bioanalytical Method Validations of Three Alpha1-Antitrypsin Measurement Methods Required for Clinical Sample AnalysisPharmaceuticals · 2025
12. Spinal Stenosis: An Emerging Complication of Ageing in People With HaemophiliaHaemophilia · 2025
13. Real-world use of protein C concentrate for the treatment of patients with protein C deficiency: an international registryJournal of Thrombosis and Haemostasis · 2025
14. Unsupervised optimization of spectral pre-processing selection to achieve transfer of Raman calibration modelsMeasurement · 2025
15. Comparison of spectroscopic techniques for determination of protein secondary structureSpectrochimica Acta Part A Molecular and Biomolecular Spectroscopy · 2025
16. Clinical Study Support by Long-Term Stability Studies of Alpha1-Proteinase Inhibitor and Urea in Relevant Biological MatricesPharmaceuticals · 2025
17. Iterative hybrid model based optimization of rAAV productionBiotechnology Progress · 2025
18. Enhanced α2-3–linked sialylation determines the extended half-life of CHO-rVWFBlood · 2025
19. Efficacy, Safety, Tolerability, and Serum IgG Trough Levels of Hyaluronidase-Facilitated Subcutaneous Immunoglobulin 10% in US Pediatric Patients with Primary Immunodeficiency DiseasesJournal of Clinical Immunology · 2025
20. Preclinical development of TAK-754, a high-performance AAV8-based vector expressing coagulation factor VIIIMolecular Therapy — Methods & Clinical Development · 2025